NO154549B - PROCEDURE FOR PREPARING ETHYLENDIA ACETATE. - Google Patents
PROCEDURE FOR PREPARING ETHYLENDIA ACETATE. Download PDFInfo
- Publication number
- NO154549B NO154549B NO812501A NO812501A NO154549B NO 154549 B NO154549 B NO 154549B NO 812501 A NO812501 A NO 812501A NO 812501 A NO812501 A NO 812501A NO 154549 B NO154549 B NO 154549B
- Authority
- NO
- Norway
- Prior art keywords
- group
- androstan
- carbon atoms
- parts
- thiocyanate
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 230000001195 anabolic effect Effects 0.000 claims description 4
- 230000001548 androgenic effect Effects 0.000 claims description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 3
- 230000001833 anti-estrogenic effect Effects 0.000 claims description 3
- 230000002349 favourable effect Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 3
- 150000003431 steroids Chemical class 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- -1 Alkylidene diesters Chemical class 0.000 abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 229910017052 cobalt Inorganic materials 0.000 abstract 1
- 239000010941 cobalt Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000007858 starting material Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- GCKMFJBGXUYNAG-UHFFFAOYSA-N 17alpha-methyltestosterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C)(O)C1(C)CC2 GCKMFJBGXUYNAG-UHFFFAOYSA-N 0.000 description 3
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229960001566 methyltestosterone Drugs 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- CIHXIRAAMAUYLZ-UHFFFAOYSA-N [K+].[K+].[C-]#[C-] Chemical compound [K+].[K+].[C-]#[C-] CIHXIRAAMAUYLZ-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- WMWXXXSCZVGQAR-UHFFFAOYSA-N dialuminum;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3] WMWXXXSCZVGQAR-UHFFFAOYSA-N 0.000 description 1
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000011981 lindlar catalyst Substances 0.000 description 1
- HTBVGZAVHBZXMS-UHFFFAOYSA-N lithium;tris[(2-methylpropan-2-yl)oxy]alumane Chemical compound [Li].[Al+3].CC(C)(C)[O-].CC(C)(C)[O-].CC(C)(C)[O-] HTBVGZAVHBZXMS-UHFFFAOYSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/20—Carbonyls
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C27/00—Processes involving the simultaneous production of more than one class of oxygen-containing compounds
- C07C27/04—Processes involving the simultaneous production of more than one class of oxygen-containing compounds by reduction of oxygen-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/10—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/003—Esters of saturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/16—Acetic acid esters of dihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
lkylideirdiestere fremstilles ved å omsette karboksyl-yreanhydrider med hydrogen i nærvær av en koboltkar-bonylkatalysator.Alkylidene diesters are prepared by reacting carboxylic anhydrides with hydrogen in the presence of a cobalt carbonyl catalyst.
Description
Fremgangsmåte for fremstilling av 2a,3a-epitio-steroider med terapeutisk virkning. Process for the production of 2a,3a-epithio-steroids with therapeutic effect.
Foreliggende oppfinnelse angår en The present invention relates to a
fremgangsmåte for fremstilling av 2a, 3 a-epitiosteroider med antiøstrogen virkning og et gunstig forhold mellom sterk androgen og sterk anabolsk virkning og med den generelle formel process for the production of 2a, 3a-epithiosteroids with antiestrogenic action and a favorable ratio between strong androgenic and strong anabolic action and with the general formula
hvori R er en alkylgruppe, en alkenyl-gruppe eller en alkynyl-gruppe med hver ikke over 5 karbonatomer, og det særegne ved fremgangsmåten i henhold til oppfin-nelsen er karakterisert ved at et steroid med følgende generelle formel in which R is an alkyl group, an alkenyl group or an alkynyl group each with no more than 5 carbon atoms, and the peculiarity of the method according to the invention is that a steroid with the following general formula
hvori R har den ovennevnte betydning, R' er en cyan-gruppe eller en alkanoyl-gruppe med ikke mer enn 6 karbonatomer, og R" er et hydrogenatom, en alkanoyl-gruppe med ikke mer enn 6 karbonatomer, en alkyl-sulfonyl-gruppe med ikke mer enn 5 karbonatomer, en fenyl-sulfonylgruppe eller en alkyl-fenyl-sulfonylgruppe med ikke mer enn 11 karbonatomer omsettes med et basisk reagerende middel. wherein R has the above meaning, R' is a cyano group or an alkanoyl group of not more than 6 carbon atoms, and R" is a hydrogen atom, an alkanoyl group of not more than 6 carbon atoms, an alkyl sulfonyl group with not more than 5 carbon atoms, a phenyl-sulfonyl group or an alkyl-phenyl-sulfonyl group with not more than 11 carbon atoms is reacted with a basic reacting agent.
Utgangsforbindelse kan fremstilles fra det tilsvarende 2|3, 3|3-epoksy-steroid ved en rekke metoder. En av metodene er illustrerende representerbar ved det følgende skje-ma som bare viser A-ringen i steroid-kjernen: The starting compound can be prepared from the corresponding 2|3,3|3-epoxy-steroid by a number of methods. One of the methods can be illustratively represented by the following scheme, which only shows the A ring in the steroid nucleus:
hvori R' har den ovennevnte betydning, R"' er en alkanoyl-gruppe med ikke mer enn 6 karbonatomer, som acetyl, propionyl eller butyryl, en alkyl-sulfonyl-gruppe med wherein R' has the above meaning, R"' is an alkanoyl group of not more than 6 carbon atoms, such as acetyl, propionyl or butyryl, an alkyl-sulfonyl group of
ikke mer enn 5 karbonatomer, som metan-sulfonyl eller etansulfonyl, en fenyl-sulfonyl-gruppe eller en alkylfenyl-sulfonyl-gruppe med ikke mer enn 11 karbonatomer, not more than 5 carbon atoms, such as methanesulfonyl or ethanesulfonyl, a phenylsulfonyl group or an alkylphenylsulfonyl group of not more than 11 carbon atoms,
som toluensulfonyl eller xylensulfonyl, og X er et halogenatom, som klor eller brom, eller en hydroksyl-gruppe. such as toluenesulfonyl or xylenesulfonyl, and X is a halogen atom, such as chlorine or bromine, or a hydroxyl group.
Eksempler på utgangsforbindelse om-fatter 3a-tiocyanat-17a-etyl-5a-androstan-2(3,17i(3-diol, 3a-tiocyanat-17a-vinyl-5a-androstan-2(3,17[3-diol, 3a-tiocyanat-17a-etynyl-5a-androstan-2p,17|3-diol, 2|3-metansulfonyloksy-3a-tiocyanat- 17a-metyl-5a-androstan-17p-ol, 2j3-metansul-fonyloksy-3a-tiocyanat-17a-vinyl-5a-androstan-17|3-ol, 2|3-toluensulf onyloksy-3a-tlocyanat-17a-etyl-5a-androstan-17|3-ol, 2|3-acetyloksy-3a-tiocyanat-17a-metyl-5a-androstan-17|3-ol og 2|3-propionyloksy-3a-propionyltio- 17o-vinyl-5a-androstan-17p-ol. Examples of the starting compound include 3α-thiocyanate-17α-ethyl-5α-androstane-2(3,17[3-diol, 3α-thiocyanate-17α-vinyl-5α-androstane-2(3,17[3-diol, 3a-thiocyanate-17a-ethynyl-5a-androstane-2p,17|3-diol, 2|3-methanesulfonyloxy-3a-thiocyanate- 17a-methyl-5a-androstane-17p-ol, 2j3-methanesulfonyloxy-3a- thiocyanate-17a-vinyl-5a-androstan-17|3-ol, 2|3-toluenesulfonyloxy-3a-tlocyanate-17a-ethyl-5a-androstan-17|3-ol, 2|3-acetyloxy-3a-thiocyanate -17a-methyl-5a-androstan-17|3-ol and 2|3-propionyloxy-3a-propionylthio-17o-vinyl-5a-androstan-17p-ol.
Ved fremgangsmåten i henhold til opp-finnelsen behandles utgangsmaterialet med et basisk middel for å gi det tilsvarende 2a,3a-epitio-steroid. Som basisk middel kan det anvendes en svak base som f. eks. alu-miniumoksydhydrat og en sterk base som f. eks. kaliumhydroksyd og natriumhydrok-syd. Andre basiske midler som f. eks. nat-rium-karbonat og kalium-karbonat kan også anvendes! om så ønskes. Reaksjons-temperaturen avhenger av utgangsmaterialet og det basiske middel. For fremstilling av de ønskede forbindelser med godt utbytte, foretrekkes det vanligvis å utføre omsetningen i et inert oppløsningsmiddel, som metanol, etanol, propanol, benzen, to-luen, petroleter eller dimetylen-glykol-di-metyl-eter, under relativt milde betingel-ser, dvs. ved en temperatur ikke over 100°C. In the method according to the invention, the starting material is treated with a basic agent to give the corresponding 2a,3a-epithio-steroid. A weak base such as e.g. aluminum oxide hydrate and a strong base such as potassium hydroxide and sodium hydroxide. Other basic agents such as e.g. sodium carbonate and potassium carbonate can also be used! if desired. The reaction temperature depends on the starting material and the basic agent. For the preparation of the desired compounds in good yield, it is usually preferred to carry out the reaction in an inert solvent, such as methanol, ethanol, propanol, benzene, toluene, petroleum ether or dimethyl glycol dimethyl ether, under relatively mild conditions -ser, i.e. at a temperature not exceeding 100°C.
De ved hj elp av fremgangsmåten frem-stillbare 2a,3a-epitio-steroider spesielt 2a, 3a-epitio-17a-metyl-5a-androstan-17|3-ol og 2a,3a-epitio-17a-etyl-5a-androstan-17a-ol, fremviser en fordelaktig antiøstro-gen virkning. The 2a,3a-epithio-steroids that can be produced by the method, especially 2a,3a-epithio-17a-methyl-5a-androstan-17|3-ol and 2a,3a-epithio-17a-ethyl-5a-androstane -17α-ol, exhibits a beneficial antiestrogenic effect.
Videre ble sterke androgene og ana-bolske virkninger med gunstig forhold mellom anabolsk-androgen bekreftet ved 2a, 3a-epitio-17a-metyl-5a-androstan-17|3-ol (ME) og 2a,3a-epitio-17a-etyl-5a-andros-tan-17a-ol (EE) ved sammenlignende prøve ved kastrerte unge hanrotter som veide omtrent 50 g, like overfor standard-for-bindelsen metyltestosteron (MT). Forbin-delsene ble henhv. tilført oralt i 10 påføl-gende døgn ved den angitte totale dose pr. rotte og sluttpunktene (vekt av sædeblære, Ventral Prostata og Levator Ani Muskel) ble bestemt etter 11 dager ved autopsi. Re-sultatene er oppsummert i følgende tabell I. Furthermore, strong androgenic and anabolic effects with a favorable anabolic-androgenic ratio were confirmed by 2a,3a-epithio-17a-methyl-5a-androstan-17|3-ol (ME) and 2a,3a-epithio-17a-ethyl -5α-andros-tan-17α-ol (EE) in a comparative test in castrated young male rats weighing approximately 50 g, equal to the standard compound methyltestosterone (MT). The connections were respectively administered orally for 10 consecutive days at the indicated total dose per rat and the endpoints (weight of seminal vesicle, Ventral Prostate and Levator Ani Muscle) were determined after 11 days at autopsy. The results are summarized in the following table I.
Resultatet av beregningene er oppsummert i tabell II, hvori det utmerkete forhold mellom anabolsk/androgen (3—7), sammenlignet med forholdet = 1 for stan— dard-metyltestosteron, fremgår. The result of the calculations is summarized in table II, in which the excellent ratio between anabolic/androgenic (3-7), compared to the ratio = 1 for standard methyltestosterone, is shown.
De følgende eksempler representerer illustrerende og eksempelvise utførelsesfor-mer for fremgangsmåten i henhold til opp-finnelsen. Forholdet mellom vektdeler og volumdeler er det samme som mellom gram og milliliter. The following examples represent illustrative and exemplary embodiments of the method according to the invention. The ratio between parts by weight and parts by volume is the same as between grams and milliliters.
Eksempel 1. Example 1.
Fremstilling av 2a,3a-epitio-17a-etyl-5a-androstan-17(3-ol. Preparation of 2a,3a-epithio-17a-ethyl-5a-androstan-17(3-ol.
Til en oppløsning av 3a-tiocyanat-17a-etyl-5a-androstan-2|3,17(3-diol (3,74 vektdeler) i dioksan (60 volumdeler) tilsettes en oppløs-ning av kaliumkarbonat (5,5 vektdeler) i vann (30 volumdeler) og metanol (100 volumdeler), og den resulterende blanding får stå ved romtemperatur (ca. 15°C). Reaksjonsblandingen konsentreres under redusert trykk og vann tilsettes deretter. Bunnfallet oppsamles ved filtrering, krystalliseres fra en blanding av eter og petroleter og rekrystalliseres fra en blanding av aceton og heksan slik at det fås 2a,3a-epitio-17a-etyl-5a-androstan-17|3-ol ( 2, 49 vektdeler) som krystaller som smelter ved 146—148°C. (a) V's + 8,5 ± 2° (c - 1,029 i kloroform). To a solution of 3a-thiocyanate-17a-ethyl-5a-androstane-2|3,17(3-diol (3.74 parts by weight) in dioxane (60 parts by volume) is added a solution of potassium carbonate (5.5 parts by weight) in water (30 parts by volume) and methanol (100 parts by volume), and the resulting mixture is allowed to stand at room temperature (about 15°C). The reaction mixture is concentrated under reduced pressure and water is then added. The precipitate is collected by filtration, crystallized from a mixture of ether and petroleum ether and recrystallized from a mixture of acetone and hexane so that 2a,3a-epithio-17a-ethyl-5a-androstan-17|3-ol (2.49 parts by weight) is obtained as crystals melting at 146-148°C .(a) V's + 8.5 ± 2° (c - 1.029 in chloroform).
IR: 3660, 3630 cm-<1>. IR: 3660, 3630 cm-<1>.
Analyse beregnet for C21H34<O>S: C,75.39; H 10.24; S 9.58. Analysis calculated for C21H34<O>S: C,75.39; H 10.24; S 9.58.
Funnet: C.75.52, H, 10.35, S, 9,74. Utgangsmaterialet i dette eksempel, 3a-tiocyanat-17a-etyl-5a-androstan-2p, 17(3-diol kan fremstilles ved å reagere 2(3, 3|3-epoksy-5a-androstan-17-on (J. Fajkos Found: C.75.52, H, 10.35, S, 9.74. The starting material in this example, 3α-thiocyanate-17α-ethyl-5α-androstan-2β, 17(3-diol can be prepared by reacting 2(3, 3|3-epoxy-5α-androstan-17-one (J. Fajkos
et al.: Chem. Abstracts Vol. 53, side 5343 et al.: Chem. Abstracts Vol. 53, page 5343
(1959)) med kaliumacetylid i en blanding (1959)) with potassium acetylide in a mixt
av tetrahydrofuran og eter ved romtemperatur, redusere katalytisk det resulterende 2p,3(3-epoksy-17a-etynyl-5a-androstan-17p-ol under anvendelse av palladium-kal-sium-karbonat i etylacetat og å reagere det resulterende 2p,3p-epoksy-17a-etyl-5a-androstan-17p-ol med en oppløsning av tiocyansyre i eter ved romtemperatur. of tetrahydrofuran and ether at room temperature, catalytically reducing the resulting 2p,3(3-epoxy-17a-ethynyl-5a-androstan-17p-ol using palladium-calcium carbonate in ethyl acetate and reacting the resulting 2p,3p -epoxy-17α-ethyl-5α-androstan-17β-ol with a solution of thiocyanic acid in ether at room temperature.
Eksempel 2. Example 2.
Fremstilling av 2cx,3a-epitio-17a-vinyl-5a-androstan-17p-ol. Preparation of 2cx,3a-epithio-17a-vinyl-5a-androstan-17p-ol.
3a-tiocyanat-17a-vinyl-5a-androstan-2p,17p-dlol behandles med kaliumkarbonat i en blanding av dioksan og vann som i eksempel 1, og gir 2a, 3a-epito-17a-vinyl-5a-androstan-17p-ol som krystaller som smelter ved 136—138°C. 3a-thiocyanate-17a-vinyl-5a-androstane-2p,17p-dlol is treated with potassium carbonate in a mixture of dioxane and water as in Example 1, giving 2a,3a-epito-17a-vinyl-5a-androstane-17p- etc. as crystals that melt at 136-138°C.
(a) V5 + 17.5 ± 2° (c = 1.043 i kloro-, T_ Nu jol form).IR:r Max (a) V5 + 17.5 ± 2° (c = 1.043 in chloro-, T_ Nu jol form).IR:r Max
3348, 3088, 1642, 1014, 924, 910 cm-<1>. 3348, 3088, 1642, 1014, 924, 910 cm-<1>.
Analyse beregnet for <C>21H32OS: C.75.85; Analysis calculated for <C>21H32OS: C.75.85;
H,9.70; S,9.64. H, 9.70; S, 9.64.
Funnet: C,75.98; H,9.80; S.9.86. Utgangsmaterialet i dette eksempel, 3a-tiocyanat-17a-vinyl-5a-androstan-2p, Found: C,75.98; H, 9.80; P.9.86. The starting material in this example, 3α-thiocyanate-17α-vinyl-5α-androstane-2β,
17p-diol, kan fremstilles ved katalytisk re-duksjon av 2p,3ip-epoksy-17a-etynyl-5a-androstan-17p-ol under anvendelse av Lindlar katalysator i etylacetat og å reagere det resulterende 2p,3p-epoksy-17a- 17p-diol, can be prepared by catalytic reduction of 2p,3p-epoxy-17a-ethynyl-5a-androstan-17p-ol using Lindlar catalyst in ethyl acetate and reacting the resulting 2p,3p-epoxy-17a-
vinyl-5a-androstan-17:|3-ol med en oppløs-ning av tiocyansyre i eter ved romtemperatur. vinyl-5α-androstan-17:|3-ol with a solution of thiocyanic acid in ether at room temperature.
Eksempel 3. Example 3.
Fremstilling av 2a,3a-epitio-l-7a-etynyl-5a-androstan-17|3-ol. Preparation of 2α,3α-epithio-1-7α-ethynyl-5α-androstan-17|3-ol.
3a-tiocyanat-17aretynyl-5a^androstan-2(3,17(3-diol behandles med. kaliumkarbonat i en blanding av dioksan og vann som i eksempel 1, og gir 2a,3a-epitio-17a-etynyl-5a-androstan-17(3-ol som krystaller som smelter ved 177—1.78°C. 3a-thiocyanate-17arethynyl-5a^androstane-2(3,17(3-diol) is treated with potassium carbonate in a mixture of dioxane and water as in example 1, giving 2a,3a-epithio-17a-ethynyl-5a-androstane -17(3-ol as crystals melting at 177—1.78°C.
(a) V<5> — 19-0 ± 2° (C = 1.038 i kloro-, ___ Nujol form). IR:r m^ (a) V<5> — 19-0 ± 2° (C = 1.038 in chloro-, ___ Nujol form). IR:r m^
3405, 3294, 1047 cm-<1>. 3405, 3294, 1047 cm-<1>.
Analyse beregnet for C2LH30OS: C.76.31; H.9.15; S.9.70. Analysis calculated for C2LH30OS: C.76.31; H.9.15; P.9.70.
Funnet:. C.76.38;. H.9.00; S.9.79. Found: C.76.38;. H.9.00; P.9.79.
Utgangsmaterialet 1 dette, eksempel,, 3a-tiocyanat-17a-etynyl-5arandrostan-2(3„ 17§-diol kan fremstilles ved. å. reagere. 2$,, The starting material 1 this, for example, 3α-thiocyanate-17α-ethynyl-5arandrostane-2(3„ 17§-diol can be prepared by reacting
3prepoksy.-l'7a-etynyl-5a-androstan^I7§-ol medi en oppløsning, av tiocyansyre i eter ved romtemperatur. 3-prepoxy.-1'7a-ethynyl-5a-androstan^17§-ol with a solution of thiocyanic acid in ether at room temperature.
Eksempel 4. Example 4.
Fremstilling, av 2a-3a-epitio,-17ar-me-tyl-5a-androstan-1.7p-oL. Preparation of 2α-3α-epithio,-17α-methyl-5α-androstane-1.7β-oL.
Til en oppslemning av 2|3-metansul-fonyloksy-3a-tiocyanat-17a-metyl-5a-androstan-17)3-ol (2.15 vektdeler) ren blanding av metylenglykoldimetyleter (50 vo-lumdeTer)' og tetrahydrofuran* (IO- volumdeler), tilsettes- en oppløsning av kaliumhydroksyd (2.5 vektdeler) r vann (4: volumdeler) og" den resulterende oppløsning om-røres- natten over ved romtemperatur (ca. 15 °C). Ti! reaksjonsblandingen tilsettes-vann; og- den resulterende blanding rystes* med diklormetan. Diklormetanskiktet vas-kes med vann, tørres-og inndampes til tørr-het. Resten kromatograferespå aluminium-oksyd (35 vektdeler). Eluatene med en blanding- av petroleter og- benzen (1 : 2), benzen og en blanding, av benzen og eter (95 : 5)' kombineres; konsentreres^ og krystalliseres fra vandig aceton til å gi 2 a, 3 a-epitio-17a-metyl-5a-androstan-17|3-ol (0.91 vektdeler) som nåler som smelter ved 168—169°C. (a) \7 ;- 5 + 3:4 ± 2°. (>c = l<i>.045 i kloro-Nuiol-. To a slurry of 2|3-methanesulfonyloxy-3a-thiocyanate-17a-methyl-5a-androstan-17)3-ol (2.15 parts by weight) pure mixture of methylene glycol dimethyl ether (50 vol. deTer)' and tetrahydrofuran* (10- parts by volume), a solution of potassium hydroxide (2.5 parts by weight) in water (4: parts by volume) is added and the resulting solution is stirred overnight at room temperature (approx. 15 °C). Water is added to the reaction mixture; and the resulting mixture is shaken* with dichloromethane. The dichloromethane layer is washed with water, dried and evaporated to dryness. The residue is chromatographed on aluminum oxide (35 parts by weight). The eluates with a mixture of petroleum ether and benzene (1:2), benzene and a mixture, of benzene and ether (95 : 5)' are combined; concentrated^ and crystallized from aqueous acetone to give 2a, 3a-epithio-17a-methyl-5a-androstan-17|3-ol (0.91 parts by weight) as needles melting at 168—169° C. (a) \7 ;- 5 + 3:4 ± 2°. (>c = l<i>.045 in chloro-Nuiol-.
form). IR:y m^x 3356 cm-1.shape). IR:y m^x 3356 cm-1.
Analyse beregnet for C20H3„QS:. C.74.94; H.1-0-.06;. 840-00. Analysis calculated for C20H3„QS:. C.74.94; H.1-0-.06;. 840-00.
Funnet G]75lll;: H,r0sH7-;: S',9186.. Utgangsmaterialet r dette eksempel? 2p-metan-sulfbnyloksy-3d-tiocya-nat-17a-metyl-Sct-androstan-lTp-ol, kan fremstilles ved- å behandle 2- a-brom-17a-metyr-l'7p-hydroksy-5a-androstan-3-on' (CounselF et al.: J. Org. Chem. Vol. 27, side 248 (1962)) med litium-tri-t-butoksy-aluminium-hydrid, behandle- det resulterende produkt med kaliumhydroksyd i isopropanol, behandle dtefr resulterende^ 2(}3p:-epoksy-l-7a-metyl-Sa-androstan-ITfV-ol med1 tiocyansyre i eter og å behandle det resulterende 2|3-hydroksy-3a-tiocyanat-17a-metyl-5a-androstan-17(3-ol med metansulfonylklorid i pyrldin.. Found G]75lll;: H,r0sH7-;: S',9186.. Is the starting material r this example? 2p-methane-sulfynyloxy-3d-thiocyanate-17a-methyl-Sct-androstan-1Tp-ol, can be prepared by treating 2-a-bromo-17a-methyl-1'7p-hydroxy-5a-androstan- 3-on' (CounselF et al.: J. Org. Chem. Vol. 27, page 248 (1962)) with lithium tri-t-butoxy aluminum hydride, treat the resulting product with potassium hydroxide in isopropanol, treat dtefr resulting^ 2(}3p:-epoxy-1-7a-methyl-Sa-androstane-ITfV-ol with 1 thiocyanic acid in ether and treating the resulting 2|3-hydroxy-3a-thiocyanate-17a-methyl-5a-androstane -17(3-ol with methanesulfonyl chloride in pyrldine..
Eksempel 5. Example 5.
Fremstillav 2a,3a-epitio-17a-etyl-5a-androstan-17f3-ol. Preparation of 2a,3a-epithio-17a-ethyl-5a-androstan-17f3-ol.
En oppløsning av 2fS-metansulfonyl-oksy-3a-tiocyanat-17a-etyl-5a-androstan-17(3-ol (3.5 vektdeler) i tetrahydrofuran (20 A solution of 2fS-methanesulfonyl-oxy-3a-thiocyanate-17a-ethyl-5a-androstan-17(3-ol (3.5 parts by weight) in tetrahydrofuran (20
volumdeler) tilsettes til en oppløsning av parts by volume) is added to a solution of
kaliumhydroksyd (3.5 vektdeler) i isopropanol (70 volumdeler) og den resulterende potassium hydroxide (3.5 parts by weight) in isopropanol (70 parts by volume) and the resulting
blanding omrøres. Reaksjonsblandingen mixture is stirred. The reaction mixture
homogeniseres med en liten mengde vann, homogenize with a small amount of water,
og får henstå over natten. En større vann-mengde tilsettes, og den resulterende opp-løsning rystes med diklormetan. Diklormetanskiktet kromatograferes på alumi-niumoksyd (80 vektdeler). Eluatene med and leave overnight. A larger quantity of water is added, and the resulting solution is shaken with dichloromethane. The dichloromethane layer is chromatographed on aluminum oxide (80 parts by weight). The eluates with
benzen og en blanding av benzen og eter benzene and a mixture of benzene and ether
(95 : 1, 9 : 1) kombineres, krystalliseres fra (95 : 1, 9 : 1) are combined, crystallized from
en blanding av eter og metanol, og rekrystalliseres fra en blanding av di-klormetan a mixture of ether and methanol, and recrystallized from a mixture of dichloromethane
og metanol til å gi 2a,3aepitio-17a-etyl-5a-androstan-17'|3-ol-hydrat (2.46 vektdeler) som nåler som smelter ved 146—148°C. and methanol to give 2α,3α-epithio-17α-ethyl-5α-androstan-17'|3-ol hydrate (2.46 parts by weight) as needles melting at 146-148°C.
Nålene krystalliseres fra en blanding av The needles are crystallized from a mixture of
aceton og heksan og gir 2a,3«-epitio-17a-etyl-5a-androstan-17|3-ol (2.11 vektdeler) acetone and hexane and gives 2a,3«-epithio-17a-ethyl-5a-androstan-17|3-ol (2.11 parts by weight)
som smelter ved 147—149°C. which melts at 147-149°C.
(a) V'<5> + 8.5 ± 2° (c = 1.029 i kloroform). IR:y 3660, 3630 cm-<1>. (a) V'<5> + 8.5 ± 2° (c = 1.029 in chloroform). IR: y 3660, 3630 cm-<1>.
Analyse beregnet for C21H34<O>S: 0,75.39; Analysis calculated for C21H34<O>S: 0.75.39;
H.10.24; S.9.58. H.10.24; P.9.58.
Funnet: 0,75.52; H,10.35; S.9.74. Found: 0.75.52; H, 10.35; P.9.74.
Utgangsmaterialet i dette eksempel, The starting material in this example,
2|3-metansulfonyloksy-3a-tiocyanat-17a-etyl-5a-androstan-17j3-ol kan fremstilles 2|3-methanesulfonyloxy-3a-thiocyanate-17a-ethyl-5a-androstan-17j3-ol can be prepared
ved å behandle 3a-tiocyanat-17a-etyl-5a-androstan-2|3,17|3-diol med metansulfonylklorid i pyridin. by treating 3α-thiocyanate-17α-ethyl-5α-androstane-2|3,17|3-diol with methanesulfonyl chloride in pyridine.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17106480A | 1980-07-22 | 1980-07-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO812501L NO812501L (en) | 1982-01-25 |
NO154549B true NO154549B (en) | 1986-07-07 |
NO154549C NO154549C (en) | 1986-10-15 |
Family
ID=22622359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO812501A NO154549C (en) | 1980-07-22 | 1981-07-21 | PROCEDURE FOR PREPARING ETHYLENDIA ACETATE. |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS5753433A (en) |
KR (1) | KR840001306B1 (en) |
AR (1) | AR226116A1 (en) |
BE (1) | BE889678A (en) |
BR (1) | BR8104727A (en) |
CA (1) | CA1165774A (en) |
DE (1) | DE3129013C2 (en) |
FR (1) | FR2495140A1 (en) |
GB (1) | GB2079753B (en) |
IT (1) | IT1142588B (en) |
NL (1) | NL8103339A (en) |
NO (1) | NO154549C (en) |
SE (1) | SE449861B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3407092A1 (en) * | 1984-02-28 | 1985-08-29 | Hoechst Ag | Process for the preparation of ethylidene diacetate and/or ethyl acetate |
JPS63101348A (en) * | 1986-10-20 | 1988-05-06 | Idemitsu Kosan Co Ltd | Production of 1,1-diester |
-
1981
- 1981-07-10 CA CA000381565A patent/CA1165774A/en not_active Expired
- 1981-07-14 NL NL8103339A patent/NL8103339A/en not_active Application Discontinuation
- 1981-07-16 AR AR286118A patent/AR226116A1/en active
- 1981-07-17 IT IT48919/81A patent/IT1142588B/en active
- 1981-07-20 BE BE0/205444A patent/BE889678A/en not_active IP Right Cessation
- 1981-07-21 NO NO812501A patent/NO154549C/en unknown
- 1981-07-21 GB GB8122415A patent/GB2079753B/en not_active Expired
- 1981-07-21 FR FR8114158A patent/FR2495140A1/en active Granted
- 1981-07-22 SE SE8104479A patent/SE449861B/en not_active IP Right Cessation
- 1981-07-22 KR KR1019810002661A patent/KR840001306B1/en active
- 1981-07-22 JP JP56115002A patent/JPS5753433A/en active Pending
- 1981-07-22 BR BR8104727A patent/BR8104727A/en unknown
- 1981-07-22 DE DE3129013A patent/DE3129013C2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
SE449861B (en) | 1987-05-25 |
KR840001306B1 (en) | 1984-09-11 |
BR8104727A (en) | 1982-04-13 |
NO154549C (en) | 1986-10-15 |
JPS5753433A (en) | 1982-03-30 |
BE889678A (en) | 1982-01-20 |
GB2079753B (en) | 1984-09-05 |
AR226116A1 (en) | 1982-05-31 |
IT1142588B (en) | 1986-10-08 |
SE8104479L (en) | 1982-01-23 |
FR2495140A1 (en) | 1982-06-04 |
NO812501L (en) | 1982-01-25 |
DE3129013A1 (en) | 1982-03-11 |
CA1165774A (en) | 1984-04-17 |
FR2495140B1 (en) | 1984-04-27 |
DE3129013C2 (en) | 1984-05-10 |
NL8103339A (en) | 1982-02-16 |
IT8148919A0 (en) | 1981-07-17 |
KR830006161A (en) | 1983-09-17 |
GB2079753A (en) | 1982-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0000533B1 (en) | N-substituted 9,10-dihydrolysergic acid esters and a method for their preparation | |
US3235564A (en) | Intermediates to certain sulfur-containing ortho-fused polycyclic pyrazole derivatives | |
Djerassi et al. | A New Route to 1-Oxygenated Steroids1 | |
Schaffer et al. | Structure of 5-Aldo-1, 2-O-isopropylidene-D-xylo-pentofuranose1 | |
US3158619A (en) | Certain sulfur-containing ortho-fused polycyclic pyrazole derivatives | |
NO140978B (en) | ANALOGICAL PROCEDURE FOR PREPARATION OF THERAPEUTICALLY ACTIVE ISOKINOLINE DERIVATIVES | |
NO154549B (en) | PROCEDURE FOR PREPARING ETHYLENDIA ACETATE. | |
CH615158A5 (en) | ||
US3466279A (en) | Conessine derivatives | |
US3773758A (en) | 7alpha-cyano-17-hydroxy-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid ypsilon-lactone and related compounds | |
KAZUNO et al. | The Synthesis of Stero-bile Acid. VI. The Synthesis of Trihydroxycoprostane | |
DE2212589C3 (en) | Process for the preparation of 13 beta-R-4,9,11-gonatrienes and 13 beta-R-4,5-seco-9,11-gonadienes as intermediate products | |
Klimstra et al. | Anabolic agents. A-ring oxygenated androstane derivatives | |
Counsell et al. | Anabolic agents: derivatives of 2-halo-5α-androst-1-ene | |
DE2856578C2 (en) | 16-dimethylaminomethylene: 3-methoxy-1.3.5 (10) -östratrien-17-one, process for its production and its further processing | |
US3063985A (en) | Cyclopentanophenanthrene compounds and process | |
NO123549B (en) | ||
DE1947221A1 (en) | 3-Aza-19-hydroxy-3,19-cyclo-A-homosteroids and a process for their preparation | |
US3522272A (en) | Intermediates for the preparation of 1 - p - chlorobenzoyl - 2 - methyl - 3-indolylacetic acid compounds | |
DE2015800C3 (en) | Process for the production of 19-norsteroids and d 5 (10), 9 (U) -4-oxasteroids as intermediates | |
NarasimhaáRao | Oxidative demethylation of 4-substituted N, N-dimethylanilines with iodine and calcium oxide in the presence of methanol | |
US3272803A (en) | 2, 2-ethylenetestosterones | |
US3014028A (en) | 18-nor-steroids | |
US3489765A (en) | 1-p-chlorobenzoyl-2-aldehydo-3-indolyl acetic acid derivatives | |
Wendler et al. | An Unusual Transfer Reaction in the Steroid Series |